BVF as of Dec. 31, 2019
Portfolio Holdings for BVF
BVF holds 57 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ionis Pharmaceuticals (IONS) | 10.0 | $132M | 2.2M | 60.41 | |
| Springworks Therapeutics (SWTX) | 9.0 | $119M | 3.1M | 38.49 | |
| Ac Immune Sa (ACIU) | 7.3 | $97M | 11M | 8.52 | |
| Principia Biopharma | 7.1 | $94M | 1.7M | 54.78 | |
| Cytokinetics (CYTK) | 5.8 | $77M | 7.2M | 10.61 | |
| Xoma Corp Del (XOMA) | 5.5 | $72M | 2.6M | 27.30 | |
| ArQule | 4.5 | $60M | 3.0M | 19.96 | |
| Calithera Biosciences | 4.1 | $55M | 9.6M | 5.71 | |
| Molecular Templates | 3.6 | $47M | 3.4M | 13.98 | |
| Merus N V (MRUS) | 3.4 | $45M | 3.2M | 14.08 | |
| Glycomimetics | 3.0 | $39M | 7.4M | 5.29 | |
| Arcus Biosciences Incorporated (RCUS) | 2.7 | $36M | 3.6M | 10.10 | |
| Five Prime Therapeutics | 2.7 | $36M | 7.8M | 4.59 | |
| Replimune Group (REPL) | 2.5 | $33M | 2.3M | 14.35 | |
| Kura Oncology (KURA) | 2.1 | $28M | 2.0M | 13.75 | |
| Xenon Pharmaceuticals (XENE) | 1.9 | $26M | 1.9M | 13.11 | |
| Phathom Pharmaceuticals (PHAT) | 1.9 | $25M | 786k | 31.14 | |
| Pieris Pharmaceuticals | 1.5 | $19M | 5.3M | 3.62 | |
| Infinity Pharmaceuticals (INFIQ) | 1.3 | $17M | 17M | 0.96 | |
| Immunovant (IMVT) | 1.2 | $16M | 1000k | 15.85 | |
| Syndax Pharmaceuticals (SNDX) | 1.2 | $16M | 1.8M | 8.78 | |
| Anaptysbio Inc Common (ANAB) | 1.2 | $15M | 940k | 16.25 | |
| Blueprint Medicines (BPMC) | 1.1 | $15M | 184k | 80.11 | |
| Essa Pharma (EPIX) | 1.1 | $15M | 2.6M | 5.50 | |
| Mei Pharma | 1.0 | $13M | 5.3M | 2.48 | |
| X4 Pharmaceuticals | 0.9 | $12M | 1.1M | 10.70 | |
| Cti Biopharma | 0.8 | $11M | 6.9M | 1.58 | |
| Ideaya Biosciences (IDYA) | 0.8 | $11M | 1.4M | 7.50 | |
| Galmed Pharmaceuticals | 0.8 | $11M | 1.8M | 5.78 | |
| Prevail Therapeutics Ord | 0.8 | $10M | 657k | 15.83 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.8 | $10M | 2.7M | 3.84 | |
| Akero Therapeutics (AKRO) | 0.8 | $10M | 451k | 22.19 | |
| Corvus Pharmaceuticals (CRVS) | 0.7 | $8.9M | 1.6M | 5.44 | |
| Verastem | 0.6 | $8.5M | 6.3M | 1.34 | |
| Spero Therapeutics (SPRO) | 0.6 | $8.1M | 845k | 9.62 | |
| Selecta Biosciences | 0.6 | $7.8M | 3.3M | 2.38 | |
| Mersana Therapeutics | 0.5 | $6.8M | 1.2M | 5.73 | |
| Cytomx Therapeutics (CTMX) | 0.5 | $6.4M | 766k | 8.31 | |
| Forward Pharma A/s | 0.5 | $6.0M | 926k | 6.49 | |
| Protagonist Therapeutics (PTGX) | 0.4 | $4.8M | 683k | 7.05 | |
| Erytech Pharma Sa | 0.3 | $4.6M | 625k | 7.28 | |
| Alpine Immune Sciences | 0.3 | $4.4M | 1.1M | 3.84 | |
| Gamida Cell | 0.3 | $4.3M | 1.0M | 4.30 | |
| Genocea Biosciences (GNCAQ) | 0.3 | $4.3M | 2.1M | 2.07 | |
| Argenx Se (ARGX) | 0.3 | $4.0M | 25k | 160.52 | |
| Biolinerx | 0.3 | $3.9M | 1.7M | 2.25 | |
| Sutro Biopharma (STRO) | 0.3 | $3.8M | 345k | 11.00 | |
| Ovid Therapeutics (OVID) | 0.2 | $3.0M | 734k | 4.15 | |
| Eiger Biopharmaceuticals | 0.2 | $2.1M | 144k | 14.90 | |
| Sunesis Pharmaceuticals Inc Ne | 0.2 | $2.1M | 6.2M | 0.34 | |
| Surface Oncology | 0.1 | $2.0M | 1.1M | 1.88 | |
| Regulus Therapeutics | 0.1 | $1.8M | 2.0M | 0.89 | |
| Spring Bk Pharmaceuticals In | 0.1 | $1.5M | 952k | 1.58 | |
| Contrafect | 0.1 | $1.2M | 1.9M | 0.62 | |
| Brickell Biotech | 0.1 | $664k | 443k | 1.50 | |
| Novus Therapeutics | 0.0 | $481k | 829k | 0.58 | |
| Kezar Life Sciences | 0.0 | $468k | 117k | 4.01 |
